On the website
http://mariasmetode.no/2013/11/update-haukeland-english/
Where it says
How much time before we might receive treatment with Rituximab?
First all the patients have to go through the study, this will take two years starting when the last patient is included. All data will then have to be controlled, analyzed and published. FDA and the Norwegian «Legemiddelverket» will evaluate the data and decide wether there may be a new indication for Rituximab. This will at least take 4 years, possibly more. Rituximab will certainly not be a medication for all ME patients. As with any kind of illness or condition it is probable that different ME patients need different kind of treatments and medication
Does this mean that it's 2 years for the study and then will take an extra 4 years for analysis and evaluation, so will take 6 years? Or does it mean it will take at least 4 years in total?
